BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 22307202)

  • 21. Biphasic effects of transforming growth factor β on bone morphogenetic protein-induced osteoblast differentiation.
    de Gorter DJ; van Dinther M; Korchynskyi O; ten Dijke P
    J Bone Miner Res; 2011 Jun; 26(6):1178-87. PubMed ID: 21611961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of 1alpha,25-dihydroxyvitamin D3 on the expression of DNA replication genes.
    Eelen G; Verlinden L; van Camp M; van Hummelen P; Marchal K; de Moor B; Mathieu C; Carmeliet G; Bouillon R; Verstuyf A
    J Bone Miner Res; 2004 Jan; 19(1):133-46. PubMed ID: 14753745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oscillations in inositol 1,4,5-trisphosphate and diacyglycerol induced by vitamin D3 metabolites in confluent mouse osteoblasts.
    Grosse B; Bourdeau A; Lieberherr M
    J Bone Miner Res; 1993 Sep; 8(9):1059-69. PubMed ID: 8237475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of continuous activation of vitamin D and Wnt response pathways on osteoblastic proliferation and differentiation.
    Shi YC; Worton L; Esteban L; Baldock P; Fong C; Eisman JA; Gardiner EM
    Bone; 2007 Jul; 41(1):87-96. PubMed ID: 17513186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone morphogenetic protein-7 (OP1) and transforming growth factor-beta1 modulate 1,25(OH)2-vitamin D3-induced differentiation of human osteoblasts.
    Eichner A; Brock J; Heldin CH; Souchelnytskyi S
    Exp Cell Res; 2002 Apr; 275(1):132-42. PubMed ID: 11925111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The developmental stages of osteoblast growth and differentiation exhibit selective responses of genes to growth factors (TGF beta 1) and hormones (vitamin D and glucocorticoids).
    Lian JB; Stein GS
    J Oral Implantol; 1993; 19(2):95-105; discussion 136-7. PubMed ID: 8246305
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vitamin D inhibits Fas ligand-induced apoptosis in human osteoblasts by regulating components of both the mitochondrial and Fas-related pathways.
    Duque G; El Abdaimi K; Henderson JE; Lomri A; Kremer R
    Bone; 2004 Jul; 35(1):57-64. PubMed ID: 15207741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hydrocortisone and deflazacort induce different effects on vitamin D receptor level increase produced by 1,25-dihydroxyvitamin D3 in rat osteoblast-like UMR-106 cells.
    Guerrero R; de la Piedra C; Teixeiro E; Bragado R; Traba ML
    J Rheumatol; 2004 Jan; 31(1):167-72. PubMed ID: 14705237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alendronate interacts with the inhibitory effect of 1,25(OH)2D3 on parathyroid hormone-related protein expression in human osteoblastic cells.
    Gómez-García L; Esbrit P; Carreño L; Sabando P; García-Flores M; Martinez ME
    J Bone Miner Res; 2003 Jan; 18(1):78-87. PubMed ID: 12510808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 1Alpha,25-(OH)2D3 acts in the early phase of osteoblast differentiation to enhance mineralization via accelerated production of mature matrix vesicles.
    Woeckel VJ; Alves RD; Swagemakers SM; Eijken M; Chiba H; van der Eerden BC; van Leeuwen JP
    J Cell Physiol; 2010 Nov; 225(2):593-600. PubMed ID: 20506116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The 1,25(OH)2D3-regulated transcription factor MN1 stimulates vitamin D receptor-mediated transcription and inhibits osteoblastic cell proliferation.
    Sutton AL; Zhang X; Ellison TI; Macdonald PN
    Mol Endocrinol; 2005 Sep; 19(9):2234-44. PubMed ID: 15890672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 2010 Young Investigator Award winner: Therapeutic aprotinin stimulates osteoblast proliferation but inhibits differentiation and bone matrix mineralization.
    Schoenecker J; Mignemi N; Stutz C; Liu Q; Edwards J; Lynch C; Holt G; Schwartz H; Mencio G; Hamm H
    Spine (Phila Pa 1976); 2010 Apr; 35(9):1008-16. PubMed ID: 20407341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of different growth factors on human osteoblasts activities: a possible application in bone regeneration for tissue engineering.
    Bosetti M; Boccafoschi F; Leigheb M; Cannas MF
    Biomol Eng; 2007 Dec; 24(6):613-8. PubMed ID: 17936069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of vitamin D metabolites on the calcification of cartilage matrix and the C-propeptide of type II collagen (chondrocalcin).
    Hinek A; Poole AR
    J Bone Miner Res; 1988 Aug; 3(4):421-9. PubMed ID: 3265578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary human osteoblasts in response to 25-hydroxyvitamin D3, 1,25-dihydroxyvitamin D3 and 24R,25-dihydroxyvitamin D3.
    van der Meijden K; Lips P; van Driel M; Heijboer AC; Schulten EA; den Heijer M; Bravenboer N
    PLoS One; 2014; 9(10):e110283. PubMed ID: 25329305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RNA interference-mediated knockdown of Smad1 inhibits receptor activator of nuclear factor κB ligand expression induced by BMP-2 in primary osteoblasts.
    Yoshikawa Y; Yoshizawa T; Domae E; Hieda Y; Takeyama A; Hirota S; Kawamoto A; Goda S; Tamura I; Kamada A; Komasa Y; Morita S; Yamagata K; Ikeo T
    Arch Oral Biol; 2015 Sep; 60(9):1319-26. PubMed ID: 26123746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of osteoblast growth by interactions between transforming growth factor-beta and 1alpha,25-dihydroxyvitamin D3.
    Gurlek A; Kumar R
    Crit Rev Eukaryot Gene Expr; 2001; 11(4):299-317. PubMed ID: 12067069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exogenous regucalcin stimulates osteoclastogenesis and suppresses osteoblastogenesis through NF-κB activation.
    Yamaguchi M; Weitzmann MN; Murata T
    Mol Cell Biochem; 2012 Jan; 359(1-2):193-203. PubMed ID: 21842421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The effects of 1alpha,25-dihydroxyvitamin D3 in regulation matrix metalloproteinase and tissue metalloproteinase inhibitors in human osteoblasts].
    Guo LJ; Luo XH; Xie H; Zhou HD; Liao EY
    Zhonghua Nei Ke Za Zhi; 2005 Feb; 44(2):125-8. PubMed ID: 15840226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 1 alpha,25-Dihydroxyvitamin D3 increases transforming growth factor and transforming growth factor receptor type I and II synthesis in human bone cells.
    Wu Y; Haugen JD; Zinsmeister AR; Kumar R
    Biochem Biophys Res Commun; 1997 Oct; 239(3):734-9. PubMed ID: 9367838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.